European COPD Trials Should Have FEV1 And Clinical Benefit Endpoints
Executive Summary
Pivotal trials in support of a European indication for symptomatic benefit in chronic obstructive pulmonary disease should include both a lung function endpoint and a clinical endpoint, a European Union "points to consider" document advises.